Salvage CD20-SD-CART therapy in aggressive B-cell lymphoma after CD19 CART treatment failure
Xue, Fei, Zheng, Peihao, Yang, Fan, Liu, Rui, Feng, Shaomei, Guo, Yuelu, Shi, Hui, Ma, Lixia, Deng, Biping, Xu, Teng, Zhang, Jiecheng, Zhou, Qi, Ke, Xiaoyan, Hu, Kai
Published in Frontiers in oncology (25.06.2024)
Published in Frontiers in oncology (25.06.2024)
Get full text
Journal Article
Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing
Gao, Fan, Tian, Lei, Shi, Hui, Zheng, Peihao, Wang, Jing, Dong, Fei, Hu, Kai, Ke, Xiaoyan
Published in Frontiers in genetics (02.12.2021)
Published in Frontiers in genetics (02.12.2021)
Get full text
Journal Article
PB2326: OUTCOMES OF ANTI‐CANCER THERAPY IN PATIENTS WITH PROGRESSIVE REFRACTORY/RELAPSED B‐CELL LYMPHOMA DURING SEVERE CORONAVIRUS DISEASE 2019 (COVID‐19): A REAL‐WORLD STUDY FROM CHINA
Su, Guoai, Hu, Kai, Ke, Xiaoyan, Shi, Hui, Zheng, Peihao, Yang, Fan, Feng, Shaomei, Guo, Yuelu, MA, Liaxia, Xue, Fei, Rui, Liu, Xu, Teng, Fu, Zhonghua, Deng, Biping
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
P1173: EARLY ADMINISTRATION OF POLATUZUMAB VEDOTIN AS BRIDGING CD19‐SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY IS AN EFFECTIVE STRATEGY TO IMPROVE SURVIVAL IN PATIENTS WITH R/R B‐CELL LYMPHOMA
Yang, Fan, Liu, Rui, Fu, Zhonghua, Xu, Teng, Zheng, Peihao, Feng, Shaomei, Guo, Yuelu, MA, Lixia, Shi, Hui, Deng, Biping, Ke, Xiaoyan, Hu, Kai
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
PB2333: CAR‐T CELL THERAPY IS A EXCELLENT STRATEGY FOR R/R B‐NHL
Rui, Liu, Yang, Fan, Xue, Fei, Shi, Hui, Zheng, Peihao, MA, Lixia, Feng, Shaomei, Guo, Yuelu, Xu, Teng, Fu, Zhonghua, Deng, Biping, Ke, Xiaoyan, Hu, Kai
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
PB2101: A PROSPECTIVE INVESTIGATION INTO THE TIMING AND STATUS OF BCMA‐CART IN SECONDARY PLASMA CELL LEUKEMIA
Guo, Yuelu, Hu, Kai, Ke, Xiaoyan, Yang, Fan, MA, Lixia, Xu, Teng, Rui, Liu, Fu, Zhonghua, Zheng, Peihao, Feng, Shaomei, Shi, Hui, Deng, Biping
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA
Guo, Yuelu, Hu, Kai, Ke, Xiaoyan, Xu, Teng, Feng, Shaomei, Zheng, Peihao, MA, Lixia, Yang, Fan, Shi, Hui, Deng, Biping, Rui, Liu, Fu, Zhonghua
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
P1168: DURABLE REMISSION AFTER SEQUENTIAL CD19/20 CAR T‐CELL “CAKE‐ICING” THERAPY OCCURRED IN REFRACTORY/RELAPSED DLBCL
Zheng, Peihao, Xue, Fei, Yang, Fan, Feng, Shaomei, Guo, Yuelu, Shi, Hui, Su, Guoai, MA, Lixia, Rui, Liu, Deng, Biping, Hu, Kai, Ke, Xiaoyan
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Fault diagnosis model of main equipment in substation based on multi-mode time-frequency combination
Zheng, Peihao, Dou, Guoxian, Gao, Liang
Published in Journal of physics. Conference series (01.09.2023)
Published in Journal of physics. Conference series (01.09.2023)
Get full text
Journal Article
BCMA CAR-T induces complete and durable remission in plasmablastic lymphoma synchronous transformation of chronic lymphocytic leukemia: case report and literature review
Feng, Shaomei, Xiong, Yu, Liu, Weicheng, Liu, Haidi, Sui, Weiwei, Zheng, Peihao, Sun, Meiling, Hu, Kai, Zhang, Yajing
Published in Critical reviews in oncology/hematology (01.11.2024)
Published in Critical reviews in oncology/hematology (01.11.2024)
Get full text
Journal Article
Assessment of Activities of Daily Living (ADL)Scale Can be Used to Predict Overall Survival after CAR-T Cell Therapy in Elderly Patient(over 70 years of age) with Refractory/Relapsed B-Cell Lymphoma
Yang, Fan, Liu, Rui, Xu, Teng, Fu, Zhonghua, Zheng, Peihao, Feng, Shaomei, Guo, Yuelu, SHI, Hui, Ma, Lixia, Su, Guoai, Deng, Biping, Ke, Xiaoyan, HU, Kai
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
A Compilation of Experiences in Utilizing CAR-T Cell Therapy for Richter's Transformation
Feng, Shaomei, Xu, Teng, Liu, Haidi, Zheng, Peihao, Ma, Lixia, SHI, Hui, Wu, Tong, Yang, Fan, HU, Kai, Ke, Xiaoyan
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Exploring the Efficiency and Survival of CAR T-Cell Therapy in DLBCL Patients with MYC and/or TP53 Abnormalities
Zheng, Peihao, Liu, Rui, Xu, Teng, Yang, Fan, Feng, Shaomei, Guo, Yuelu, Ma, Lixia, Shi, Hui, Yu, Hongwei, Deng, Biping, Ke, Xiaoyan, Hu, Kai
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Subsequent Secondary CAR-T Cell Therapy Was Superior to Chemotherapy in Patients with Refractory/Relapsed B-Cell Lymphoma after Failure of Anti-CD19 CAR-T Cell Therapy
Yang, Fan, Liu, Rui, Xu, Teng, Zheng, Peihao, Feng, Shaomei, Guo, Yuelu, Ma, Lixia, SHI, Hui, Deng, Biping, Ke, Xiaoyan, Wu, Tong, Hu, Kai
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Daratumumab and venetoclax combined with CAGE for late R/R T-ALL/LBL patients: Single-arm, open-label, phase I study
Shi, Hui, Yang, Fan, Cao, Miaomiao, Xu, Teng, Zheng, Peihao, Guo, Yuelu, Su, Guoai, Feng, Shaomei, Li, Ruiting, Liu, Rui, Liu, Haidi, Ma, Lixia, Ke, Xiaoyan, Hu, Kai
Published in Annals of hematology (01.08.2024)
Published in Annals of hematology (01.08.2024)
Get full text
Journal Article
PSMB4 promotes multiple myeloma cell growth by activating NF-κB-miR-21 signaling
Zheng, Peihao, Guo, Honggang, Li, Guangchao, Han, Siqi, Luo, Fei, Liu, Yi
Published in Biochemical and biophysical research communications (06.03.2015)
Published in Biochemical and biophysical research communications (06.03.2015)
Get full text
Journal Article
Auto Hematopoietic Stem Cell Transplantation Combined with Another Target Humanized CAR-T Cells for Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma after Failure of Murinized CD19-CAR-T Therapy
Hu, Kai, Yang, Fan, Liu, Rui, Xu, Teng, Zheng, Peihao, Feng, Shaomei, Guo, Yuelu, Shi, Hui, Deng, Biping, Ke, Xiaoyan, Wu, Tong
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
The Autologous Hematopoietic Stem Cells Transplantation Combination-Based Chimeric Antigen Receptor T-Cell Therapy Improves Outcomes of Relapsed/Refractory Central Nervous System B-Cell Lymphoma
Xue, Fei, Zheng, Peihao, Liu, Rui, Feng, Shaomei, Guo, Yuelu, Shi, Hui, Liu, Haidi, Deng, Biping, Xu, Teng, Ke, Xiaoyan, Hu, Kai
Published in Journal of oncology (29.11.2022)
Published in Journal of oncology (29.11.2022)
Get full text
Journal Article
Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL
Shi, Hui, Zheng, Peihao, Liu, Rui, Xu, Teng, Yang, Fan, Feng, Shaomei, Guo, Yuelu, Ma, Lixia, Liu, Haidi, Lei, Yang, Li, Ruiting, Deng, Biping, Hou, Shuling, Li, Yang, Zheng, Qinlong, Hu, Kai, Ke, Xiaoyan
Published in Blood advances (28.03.2023)
Published in Blood advances (28.03.2023)
Get full text
Journal Article